James McCaw
#187,100
Most Influential Person Now
Mathematical biologist
James McCaw's AcademicInfluence.com Rankings
James McCawmathematics Degrees
Mathematics
#8437
World Rank
#11467
Historical Rank
Measure Theory
#4155
World Rank
#4893
Historical Rank
James McCawbiology Degrees
Biology
#15754
World Rank
#19804
Historical Rank
Mathematical Biology
#22
World Rank
#24
Historical Rank
Download Badge
Mathematics Biology
James McCaw's Degrees
- Masters Applied Mathematics Stanford University
- Bachelors Mathematics University of California, Berkeley
Similar Degrees You Can Earn
Why Is James McCaw Influential?
(Suggest an Edit or Addition)According to Wikipedia, James M. McCaw is an Australian mathematical biologist. He is professor of Mathematical Biology in the School of Mathematics and Statistics and in the Melbourne School of Population and Global Health at the University of Melbourne, where he is also Associate Dean .
James McCaw's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance (2015) (248)
- Altered temporal response of malaria parasites determines differential sensitivity to artemisinin (2013) (184)
- Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses (2014) (123)
- A Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic Infection and Immunity (2007) (102)
- Key questions for modelling COVID-19 exit strategies (2020) (98)
- Understanding influenza transmission, immunity and pandemic threats (2009) (91)
- Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease (2018) (86)
- Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model (2015) (79)
- Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. (2007) (72)
- Identifying and combating the impacts of COVID-19 on malaria (2020) (72)
- Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model (2010) (71)
- Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness (2020) (71)
- Synthetic Population Dynamics: A Model of Household Demography (2013) (71)
- Infectious disease pandemic planning and response: Incorporating decision analysis (2020) (68)
- Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection (2018) (66)
- Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model (2013) (66)
- Early analysis of the Australian COVID-19 epidemic (2020) (63)
- Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9 (2010) (55)
- Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs (2008) (55)
- Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies (2015) (54)
- Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks (2010) (50)
- Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling (2018) (46)
- Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains (2016) (45)
- Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development (2012) (45)
- The effects of demographic change on disease transmission and vaccine impact in a household structured population. (2015) (44)
- Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages (2018) (42)
- Heightened self-reactivity associated with selective survival, but not expansion, of naïve virus-specific CD8+ T cells in aged mice (2016) (41)
- Forecasting influenza outbreak dynamics in Melbourne from Internet search query surveillance data (2016) (38)
- Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria (2014) (36)
- Influenza: accounting for prior immunity. (2009) (34)
- Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact (2014) (32)
- Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia. (2012) (32)
- Characterising pandemic severity and transmissibility from data collected during first few hundred studies. (2017) (31)
- Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection (2019) (31)
- Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral Load (2013) (30)
- Making the Most of Clinical Data: Reviewing the Role of Pharmacokinetic-Pharmacodynamic Models of Anti-malarial Drugs (2014) (29)
- H1N1 influenza and the Australian macroeconomy (2012) (28)
- Within‐host modeling of blood‐stage malaria (2018) (25)
- Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic (2011) (25)
- Retrospective forecasting of the 2010–2014 Melbourne influenza seasons using multiple surveillance systems (2016) (25)
- The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment (2017) (24)
- On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection (2016) (24)
- Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. (2015) (23)
- Influenza as a trigger for cardiovascular disease: An investigation of serotype, subtype and geographic location (2017) (23)
- Influencing public health policy with data-informed mathematical models of infectious diseases: Recent developments and new challenges. (2020) (23)
- Epidemic forecasts as a tool for public health: interpretation and (re)calibration (2018) (21)
- Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host. (2016) (21)
- Accounting for Healthcare-Seeking Behaviours and Testing Practices in Real-Time Influenza Forecasts (2018) (20)
- Social encounter profiles of greater Melbourne residents, by location – a telephone survey (2015) (20)
- THE INFLUENCE OF INCREASING LIFE EXPECTANCY ON THE DYNAMICS OF SIRS SYSTEMS WITH IMMUNE BOOSTING (2012) (20)
- On the extinction probability in models of within-host infection: the role of latency and immunity (2016) (19)
- Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response (2010) (18)
- A new approach to estimating trends in chlamydia incidence (2015) (18)
- Incorporating population dynamics into household models of infectious disease transmission. (2011) (18)
- H1N1 Influenza in Australia and its Macroeconomic Effects (2010) (18)
- Optimal Dosing and Dynamic Distribution of Vaccines in an Influenza Pandemic (2009) (17)
- Quantifying relative within-host replication fitness in influenza virus competition experiments. (2015) (17)
- A Mathematical Framework for Estimating Pathogen Transmission Fitness and Inoculum Size Using Data from a Competitive Mixtures Animal Model (2011) (17)
- Coronavirus Disease Model to Inform Transmission-Reducing Measures and Health System Preparedness, Australia (2020) (16)
- Virus detection and its association with symptoms during influenza‐like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial (2012) (16)
- Household transmission of respiratory viruses – assessment of viral, individual and household characteristics in a population study of healthy Australian adults (2012) (16)
- Understanding mortality in the 1918–1919 influenza pandemic in England and Wales (2010) (15)
- Pandemic controllability: a concept to guide a proportionate and flexible operational response to future influenza pandemics (2013) (15)
- Influence of Contact Definitions in Assessment of the Relative Importance of Social Settings in Disease Transmission Risk (2012) (15)
- Model-Informed Risk Assessment and Decision Making for an Emerging Infectious Disease in the Asia-Pacific Region (2016) (14)
- A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination. (2016) (14)
- Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia (2018) (12)
- Model selection for seasonal influenza forecasting (2017) (12)
- Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context (2016) (12)
- Assessing the risk of spread of COVID-19 to the Asia Pacific region (2020) (12)
- Modelling within-host macrophage dynamics in influenza virus infection. (2020) (11)
- The dynamical consequences of seasonal forcing, immune boosting and demographic change in a model of disease transmission. (2014) (11)
- Pertussis models to inform vaccine policy (2015) (11)
- Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission (2014) (10)
- A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum (2016) (10)
- The influence of changing host immunity on 1918-19 pandemic dynamics. (2014) (10)
- Prior Population Immunity Reduces the Expected Impact of CTL-Inducing Vaccines for Pandemic Influenza Control (2015) (9)
- Factors associated with transmission of influenza-like illness in a cohort of households containing multiple children (2015) (9)
- A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection. (2017) (9)
- An Activation-Clearance Model for Plasmodium vivax Malaria (2020) (9)
- COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2 (2021) (9)
- Anatomy of a seasonal influenza epidemic forecast (2019) (8)
- Estimating temporal variation in transmission of COVID-19 and adherence to social distancing measures in Australia (2020) (8)
- Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection (2017) (8)
- Estimating the transmissibility of SARS-CoV-2 during periods of high, low and zero case incidence (2021) (7)
- Infection-acquired versus vaccine-acquired immunity in an SIRWS model (2017) (7)
- Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria. (2014) (7)
- The time-interval between infections and viral hierarchies are determinants of viral interference following influenza virus infection in a ferret model (2016) (7)
- Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling (2018) (7)
- Estimation of the probability of epidemic fade-out from multiple outbreak data (2021) (7)
- Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile (2009) (6)
- Quantifying differences in the epidemic curves from three influenza surveillance systems: a nonlinear regression analysis (2014) (6)
- Situational assessment of COVID-19 in Australia Technical Report 22 May 2022 (released 12 August 2022) (2021) (6)
- Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response. (2012) (6)
- Periodic solutions in an SIRWS model with immune boosting and cross-immunity. (2016) (6)
- Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission (2012) (6)
- Estimating temporal variation in transmission of SARS-CoV-2 and physical distancing behaviour in Australia (2020) (6)
- Hospital length of stay in a mixed Omicron and Delta epidemic in New South Wales, Australia (2022) (5)
- Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure. (2021) (5)
- Antibody Dynamics for Plasmodium vivax Malaria: A Mathematical Model (2021) (5)
- Pure point spectrum for the time evolution of a periodically rank-N kicked Hamiltonian (2004) (5)
- High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant (2016) (5)
- Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data (2019) (5)
- Coordinating the real‐time use of global influenza activity data for better public health planning (2019) (4)
- National Library of Australia Cataloguing-in-Publication entry (1999) (4)
- A decision support tool for evaluating the impact of a diagnostic-capacity and antiviral-delivery constrained intervention strategy on an influenza pandemic (2011) (4)
- The distribution of the time taken for an epidemic to spread between two communities. (2018) (4)
- Modelling within-host macrophage dynamics in influenza virus infection (2020) (4)
- From Climate Change to Pandemics: Decision Science Can Help Scientists Have Impact (2020) (4)
- In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance (2018) (3)
- Quantum Chaos: Spectral Analysis of Floquet Operators (2005) (3)
- Correction: Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral Load (2013) (3)
- Constructing an ethical framework for priority allocation of pandemic vaccines (2021) (3)
- Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics (2021) (3)
- Making the Most of Clinical Data: Reviewing the Role of Pharmacokinetic-Pharmacodynamic Models of Anti-malarial Drugs (2014) (2)
- Exploring alternate immune hypotheses in dynamical models of the 1918-1919 influenza pandemic (2011) (2)
- Estimation of the probability of epidemic fade-out from multiple outbreak data. (2022) (2)
- Rapid assessment of the risk of SARS-CoV-2 importation: case study and lessons learned (2022) (2)
- Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development (2012) (2)
- Rapid assessment of the risk of SARS-CoV-2 importation to Australia in February 2020 (2022) (2)
- On the continuous spectral component of the Floquet operator for a periodically kicked quantum system (2005) (2)
- Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task (2016) (2)
- Development of an influenza pandemic decision support tool linking situational analytics to national response policy. (2021) (2)
- Promoting Resilience While Mitigating Disease Transmission: An Australian COVID-19 Study (2021) (2)
- Proof of principle for an immunological model to explain mortality variations over the three waves of the 1918-1919 pandemic (2011) (1)
- Modelling the population dynamics of Plasmodium falciparum gametocytes in humans during malaria infection (2019) (1)
- Turnover of Village Chickens Undermines Vaccine Coverage to Control HPAI H5N1 (2017) (1)
- Forecasting COVID-19 activity in Australia to support pandemic response: May to October 2020 (2022) (1)
- Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a 'National Plan' to reopening (2022) (1)
- Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission (2012) (1)
- Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia (2023) (1)
- COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting (2022) (1)
- Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocation (2022) (1)
- Quantifying innate and adaptive immunity during influenza infection using sequential infection experiments and mathematical models (2017) (1)
- A sub-exponential branching process to study early epidemic dynamics with application to Ebola (2019) (0)
- Individual Variation in Vaccine Immune Response Can Produce Bimodal Distributions of Protection (2023) (0)
- ASSESSING PUBLIC HEALTH RESPONSES TO AN OUTBREAK OF AN EMERGED INFECTION II © Commonwealth of Australia 2007 (2007) (0)
- Corrigendum to ''Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host'' [J.Theor. Biol. 413 (2017) 34-49]. (2017) (0)
- Estimating incidence of sexually transmissible infections in Australia (2014) (0)
- Mathematical modelling for the development, monitoring and evaluation of intervention strategies for infectious diseases. (2016) (0)
- A User ' s Guide to Infectious Disease Modelling (2016) (0)
- Predicting the Outcomes of New Short-Course Regimens for Multi-Drug Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modelling (2018) (0)
- H1N1 and the Australian Macroeconomy (2011) (0)
- Modelling the biology and transmission of influenza virus - learning from 1918-19 and other outbreaks (2007) (0)
- Decision letter: Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 (2020) (0)
- New Mathematical Models of Antimalarial Drug Action to Improve Drug Dosing Regimens (2016) (0)
- A model for malaria treatment evaluation in the presence of multiple species (2022) (0)
- A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence (2023) (0)
- Author response: Early analysis of the Australian COVID-19 epidemic (2020) (0)
- Learning from the Past - an On-line Historical Database to Inform Mathematical Modelling of Influenza (2006) (0)
- Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients (2021) (0)
- A discrete-time stochastic model for partially-observed inuenza epidemics (2014) (0)
- Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling (2018) (0)
- Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission (2014) (0)
- A Mathematical Model to Determine Optimal Dosing and Dynamic Distribution of Pandemic Influenza Vaccines (2008) (0)
- Antivirals Evidence summary (2019) (0)
This paper list is powered by the following services:
Other Resources About James McCaw
What Schools Are Affiliated With James McCaw?
James McCaw is affiliated with the following schools:
